Search
for
Sort by
Research 181–210 of 1000+
- Trends in Nanotechnology for Practical Applications
- Management of tinea capitis in childhood
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- Transdermal Liposomal Delivery Systems: Advantages, Applications, Challenges, and Prospects
- 11 Managing haematologic manifestations in SLE
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Dermatologic Care of the Transplant Patient
- Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris
- Frontal fibrosing alopecia: Regrowth following cessation of sunscreen on the forehead
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- Case report of novel combination of anthralin and calcipotriene leading to trichologic response in alopecia areata
- Ethosome: a novel vesicular carrier for transdermal drug delivery
- A 32‐year‐old woman with arthralgias and severe hypotension
- Recent progress of polymeric microneedle-assisted long-acting transdermal drug delivery
- Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients
- Revolutionizing psoriasis care: Microneedle innovations in treatment and diagnosis
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Microneedles as an Emerging Platform for Transdermal Delivery of Phytochemicals
- Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Highly solubilized and skin-permeable finasteride formulation using HPCD-incorporated chitosan nanocapsules to promote hair regeneration
- Acne Syndromes and Mosaicism
- Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages
- Treatment Patterns and Treatment Satisfaction Among Adults with Alopecia Areata in the United States
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis